Wan-hong Huang
Jiayi Shi, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Methylated PIH1D1 as a Heart-Specific Biomarker for Anthracycline-Induced Cardiac Remodeling in Breast Cancer Patients.
Journal: JACC. Basic to translational science
Published: October 20, 2025
Epigenetic modulation elicits an NK cell-mediated immune response in urothelial carcinoma.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 25, 2024
Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression.
Journal: Cancer cell international
Published: August 14, 2023
PCDHB15 as a potential tumor suppressor and epigenetic biomarker for breast cancer.
Journal: Oncology letters
Published: August 17, 2021
Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma.
Journal: Cancer cell international
Published: November 04, 2020
Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers.
Journal: PloS one
Published: June 30, 2020
Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity.
Journal: Frontiers in cardiovascular medicine
Published: December 11, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026